News and Events

Clinical trial researching therapy for recurrent respiratory papillomatosis

Scott M. Norberg, D.O., Assistant Research Physician in the Center for Immuno-Oncology, is leading a trial researching drug therapy for recurrent respiratory papillomatosis.

Clinical trial researching T-cell therapy for epithelial cancers

Scott M. Norberg, D.O., Assistant Research Physician in the Center for Immuno-Oncology, is leading a trial researching T-cell therapy for gastric, breast, cervical, lung and other types of epithelial cancers.

Targeting sugar-molecule tags to proteins in the treatment of aggressive lymphomas

CCR researchers, led by Louis M. Staudt, M.D., Ph.D., have discovered a novel approach to treating diffuse large B-cell lymphoma with potentially fewer treatment-related side effects. Their work identifies and exploits the role of sugar-molecule modifications in B-cell survival.

Clinical trial researches therapy for pancreatic acinar cell carcinoma (PACC)

A clinical trial led by Christine Campo Alewine, M.D. Ph.D., Lasker Clinical Research Scholar in the Laboratory of Molecular Biology, is researching a therapy for pancreatic acinar cell carcinoma (PACC), a rare type of pancreatic tumor.

Clinical trial researching therapy for aggressive blood cancers

A clinical trial led by Christopher J. Melani, M.D., Assistant Research Physician in the Lymphoid Malignancies Branch, is researching a combination drug therapy for aggressive blood cancers, such as non-Hodgkin lymphomas.

Aligned Blog: Exploring the Model Minority Myth

May is Asian American and Native Hawaiian/Pacific Island Heritage (AANHPI) month! This month provides an opportunity to celebrate the contributions of the AANHPI community to society, culture and beyond. This year, I challenged myself to learn about something new: the Model Minority Myth. What is the myth and how does it affect the AANHPI community?

Clinical trial researches therapy for metastatic melanoma or renal cell carcinoma

A clinical trial led by Stephanie L. Goff, M.D., Associate Research Physician in the Surgery Branch, is researching a therapy for people with metastatic melanoma or renal cell carcinoma.

Clinical trial researches drug therapy for chronic graft-versus-host disease

A clinical trial led by Noa G. Holtzman, M.D., Assistant Research Physician in the Immune Deficiency Cellular Therapy Program, is researching a drug therapy for chronic graft-versus-host disease.

Clinical trial researches drug therapy for CNS tumors

A clinical trial led by Jing Wu, M.D., Ph.D., Lasker Clinical Research Scholar in the Neuro-Oncology Branch, is researching a drug therapy for aggressive diffuse gliomas.

2023 Frontiers in Basic Immunology

Dates: September 27-28, 2023
Location: Building 35, Room 610/620/630/640

The Center for Cancer Research at the National Cancer Institute is hosting a two-day national symposium on September 27-28, 2023 entitled 2023 Frontiers in Basic Immunology. The program includes recent advances in the field and should be an exciting forum for discussion and debate on the current understanding of basic immunological mechanisms. Check the website for a list of speakers.

Breadcrumb